




Searching News Database: Ranbaxy Pharmaceuticals
HSMN NewsFeed - 24 Apr 2015
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
HSMN NewsFeed - 8 May 2014
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
HSMN NewsFeed - 15 Mar 2010
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
HSMN NewsFeed - 15 Apr 2008
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
HSMN NewsFeed - 7 Feb 2008
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
HSMN NewsFeed - 6 Feb 2008
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
HSMN NewsFeed - 6 Sep 2007
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
HSMN NewsFeed - 30 Aug 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
HSMN NewsFeed - 20 Aug 2007
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
HSMN NewsFeed - 10 Jul 2007
Ranbaxy Receives Final Approval To Manufacture and Market Amlodipine Besylate Tablets
Ranbaxy Receives Final Approval To Manufacture and Market Amlodipine Besylate Tablets
HSMN NewsFeed - 20 Jun 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
HSMN NewsFeed - 17 May 2007
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
HSMN NewsFeed - 25 Apr 2007
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
HSMN NewsFeed - 11 Apr 2007
Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada
Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada
HSMN NewsFeed - 1 Feb 2007
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
HSMN NewsFeed - 31 Jan 2007
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
HSMN NewsFeed - 21 Dec 2006
Ranbaxy Granted Final FDA Approval to Market Simvastatin 5, 10, 20 and 40 mg Tablets
Ranbaxy Granted Final FDA Approval to Market Simvastatin 5, 10, 20 and 40 mg Tablets
HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
HSMN NewsFeed - 2 Nov 2006
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
HSMN NewsFeed - 21 Sep 2006
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
HSMN NewsFeed - 23 Jun 2006
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
HSMN NewsFeed - 7 Jun 2006
Ranbaxy Announces Strategic Partnership with Zenotech for Oncology Products
Ranbaxy Announces Strategic Partnership with Zenotech for Oncology Products
HSMN NewsFeed - 20 Mar 2006
Senetek and Ranbaxy Announce the Purchase by Ranbaxy of Senetek's Proprietary Autoinjector Rights and Assets
Senetek and Ranbaxy Announce the Purchase by Ranbaxy of Senetek's Proprietary Autoinjector Rights and Assets
HSMN NewsFeed - 22 Feb 2006
Takeda Wins Patent Infringement Litigation Against ANDA Filers for Generic ACTOS(R) (pioglitazone HCl)
Takeda Wins Patent Infringement Litigation Against ANDA Filers for Generic ACTOS(R) (pioglitazone HCl)
Additional items found! 78

Members Archive contains
78 additional stories matching:
Ranbaxy Pharmaceuticals
(Password required)
Ranbaxy Pharmaceuticals
(Password required)